Sun Pharmaceutical Industries consolidated net profit rises 2.56% in the September 2025 quarter
(05 Nov 2025)

Back
Net profit of Sun Pharmaceutical Industries rose 2.56% to Rs 3117.95 crore in the quarter ended September 2025 as against Rs 3040.16 crore during the previous quarter ended September 2024. Sales rose 8.60% to Rs 14405.22 crore in the quarter ended September 2025 as against Rs 13264.22 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales14405.2213264.22 9
OPM %31.4329.70 -
PBDT4897.114223.79 16
PBT4167.613597.88 16
NP3117.953040.16 3

Copyright © 2024 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)

x
  • QR-CodeNew